Laurion Capital Management LP Enanta Pharmaceuticals Inc Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$43.36 - $53.53 $354,598 - $437,768
-8,178 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$46.37 - $57.58 $379,213 - $470,889
8,178 New
8,178 $411,000
Q1 2020

May 14, 2020
SELL
$40.22 - $62.0 $245,342 - $378,200
-6,100 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$57.95 - $66.61 $353,495 - $406,321
6,100 New
6,100 $377,000

Others Institutions Holding ENTA

# of Institutions
112
Shares Held
21.2M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $110M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email